103 related articles for article (PubMed ID: 10402235)
1. Oral administration of cholic acid promotes growth of liver tumors initiated by diethylnitrosamine in rats.
Shiota G; Oyama K; Noguchi N; Takano T; Ito H; Kawasaki H
Int J Oncol; 1999 Aug; 15(2):259-65. PubMed ID: 10402235
[TBL] [Abstract][Full Text] [Related]
2. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate (DHEP).
Richmond RE; Carter JH; Carter HW; Daniel FB; Deangelo AB
Carcinogenesis; 1996 Aug; 17(8):1647-55. PubMed ID: 8761421
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
5. Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.
Dragan YP; Fahey S; Street K; Vaughan J; Jordan VC; Pitot HC
Breast Cancer Res Treat; 1994; 31(1):11-25. PubMed ID: 7981451
[TBL] [Abstract][Full Text] [Related]
6. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats.
Oyama K; Shiota G; Ito H; Murawaki Y; Kawasaki H
Carcinogenesis; 2002 May; 23(5):885-92. PubMed ID: 12016164
[TBL] [Abstract][Full Text] [Related]
7. Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine.
Williams GM; Gebhardt R; Sirma H; Stenbäck F
Carcinogenesis; 1993 Oct; 14(10):2149-56. PubMed ID: 8106178
[TBL] [Abstract][Full Text] [Related]
8. Fed before diethylnitrosamine, Fusarium moniliforme and F proliferatum mycotoxins alter the persistence of placental glutathione S-transferase-positive hepatocytes in rats.
Lebepe-Mazur S; Hopmans E; Murphy PA; Hendrich S
Vet Hum Toxicol; 1995 Jun; 37(3):209-14. PubMed ID: 7571345
[TBL] [Abstract][Full Text] [Related]
9. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis.
Sakata K; Hara A; Hirose Y; Yamada Y; Kuno T; Katayama M; Yoshida K; Zheng Q; Murakami A; Ohigashi H; Ikemoto K; Koshimizu K; Tanaka T; Mori H
Oncology; 2004; 66(3):244-52. PubMed ID: 15218316
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of protein kinase C delta is associated with a delay in preneoplastic lesion development in diethylnitrosamine-induced rat hepatocarcinogenesis.
La Porta CA; Comolli R
Carcinogenesis; 1995 May; 16(5):1233-8. PubMed ID: 7767990
[TBL] [Abstract][Full Text] [Related]
11. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
LeBoeuf RA; Laishes BA; Hoekstra WG
Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
[TBL] [Abstract][Full Text] [Related]
12. Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat.
Reddy JK; Rao MS
Br J Cancer; 1978 Oct; 38(4):537-43. PubMed ID: 728341
[TBL] [Abstract][Full Text] [Related]
13. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
14. Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.
Fujii Y; Kimura M; Ishii Y; Yamamoto R; Morita R; Hayashi SM; Suzuki K; Shibutani M
Toxicology; 2013 Mar; 305():30-40. PubMed ID: 23318833
[TBL] [Abstract][Full Text] [Related]
15. TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion.
Miller RT; Cattley RC; Marsman DS; Lyght O; Popp JA
Carcinogenesis; 1995 Jan; 16(1):77-82. PubMed ID: 7530605
[TBL] [Abstract][Full Text] [Related]
16. Promotive effect of primary and secondary bile acids on the induction of gamma-glutamyl transpeptidase-positive liver cell foci as a possible endogenous factor for hepatocarcinogenesis in rats.
Tsuda H; Masui T; Imaida K; Fukushima S; Ito N
Gan; 1984 Oct; 75(10):871-5. PubMed ID: 6150873
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of hepatocarcinogenesis initiated with diethylnitrosamine or N-nitrosobis(2-hydroxypropyl)amine by a choline-deficient, L-amino acid-defined diet administered prior to the carcinogen exposure in rats.
Kishida H; Nakae D; Kobayashi Y; Kusuoka O; Kitayama W; Denda A; Fukui H; Konishi Y
Exp Toxicol Pathol; 2000 Oct; 52(5):405-12. PubMed ID: 11089891
[TBL] [Abstract][Full Text] [Related]
18. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
[TBL] [Abstract][Full Text] [Related]
19. Correlation of O4-ethyldeoxythymidine accumulation, hepatic initiation and hepatocellular carcinoma induction in rats continuously administered diethylnitrosamine.
Dyroff MC; Richardson FC; Popp JA; Bedell MA; Swenberg JA
Carcinogenesis; 1986 Feb; 7(2):241-6. PubMed ID: 2868805
[TBL] [Abstract][Full Text] [Related]
20. Chemopreventive effects of dietary D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, on initiation and postinitiation stages of diethylnitrosamine-induced rat hepatocarcinogenesis.
Kojima T; Tanaka T; Kawamori T; Hara A; Mori H
Cancer Res; 1993 Sep; 53(17):3903-7. PubMed ID: 8358715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
